A2A Finalist

Updated: Feb 7, 2020

A2A was a finalist at RESI NYC tech hub pitch challenge

Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations...

A2A Pharmaceuticals Inc. Today Announced a Multi-target Co-development Agreement With Daewoong Pharmaceutical for AI-enhanced Oncology...